Compare ZLAB & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | HLIO |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2017 | 1996 |
| Metric | ZLAB | HLIO |
|---|---|---|
| Price | $26.49 | $68.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $49.60 | ★ $66.17 |
| AVG Volume (30 Days) | ★ 781.7K | 253.2K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | ★ 38.46 | 23.93 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $460,156,000.00 | $200,727,000.00 |
| Revenue This Year | $9.75 | $3.67 |
| Revenue Next Year | $26.03 | $5.00 |
| P/E Ratio | ★ N/A | $54.61 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $47.05 |
| 52 Week High | $34.72 | $95.05 |
| Indicator | ZLAB | HLIO |
|---|---|---|
| Relative Strength Index (RSI) | 62.61 | 40.24 |
| Support Level | $16.84 | $65.83 |
| Resistance Level | $27.22 | $76.32 |
| Average True Range (ATR) | 0.88 | 1.92 |
| MACD | -0.05 | 0.16 |
| Stochastic Oscillator | 80.44 | 38.50 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.